Polymicrobial enteric infections in African infants with diarrhoea-results from a longitudinal prospective

Melina Heinemann1, Cornelia Strauchs2, Marc Lütgehetmann3

  • 1Division of Infectious Diseases, I. Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.

Insights

Polymicrobial enteric infections are common in Ghanaian infants, with more pathogens linked to increased diarrhea risk. Many infants acquire new pathogens without developing illness, highlighting complex infection dynamics.

Area of Science:

  • Pediatric infectious diseases
  • Microbiology
  • Public health in developing nations

Background:

  • Enteric infections pose a significant health burden in infants globally.
  • Understanding pathogen prevalence and co-detection is crucial for effective treatment and prevention strategies.
  • Ghanaian infants experience high rates of diarrheal diseases, necessitating research into causative agents.

Purpose of the Study:

  • To investigate the frequency of polymicrobial enteric pathogen detection in Ghanaian infants.
  • To compare pathogen detection rates between infants with and without diarrhea.
  • To assess the association between the number of detected pathogens and diarrhea severity.

Main Methods:

  • A longitudinal case-control study involving infants aged 1-12 months.
  • Prospective assessment of infants with and without diarrhea from a peri-urban Ghanaian hospital.
  • Stool sample analysis using PCR for 18 enteric pathogens on days 0, 6, and 28.

Main Results:

  • High detection rates of at least one enteric pathogen: 93% in cases and 85% in controls.
  • Significantly higher median pathogen counts in infants with diarrhea (three) compared to controls (two).
  • Enterotoxigenic Escherichia coli, rotavirus, Giardia lamblia, and astrovirus showed the highest attributable fractions for diarrhea.

Conclusions:

  • The majority of Ghanaian infants harbor enteric pathogens, often acquired asymptomatically.
  • A higher number of co-occurring enteric pathogens may elevate the risk and severity of diarrhea.
  • Further research into asymptomatic pathogen acquisition and its implications is warranted.
Abstract

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
281
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
85.0K
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
411